Paysign (NASDAQ:PAYS) Earns Outperform Rating from Barrington Research

Barrington Research restated their outperform rating on shares of Paysign (NASDAQ:PAYS) in a research note released on Monday, Benzinga reports. They currently have a $5.50 target price on the stock.

Separately, DA Davidson upped their target price on Paysign from $4.50 to $5.50 and gave the company a buy rating in a report on Tuesday, April 30th.

Paysign Price Performance

Shares of PAYS opened at $4.57 on Monday. The firm’s 50 day moving average is $3.87 and its 200-day moving average is $3.04. Paysign has a 12-month low of $1.67 and a 12-month high of $4.80. The stock has a market capitalization of $242.07 million, a P/E ratio of 38.08 and a beta of 0.98.

Paysign (NASDAQ:PAYS) last issued its earnings results on Tuesday, March 26th. The company reported $0.10 earnings per share for the quarter. The firm had revenue of $13.69 million during the quarter, compared to analysts’ expectations of $11.57 million. Paysign had a net margin of 13.66% and a return on equity of 34.33%. As a group, equities research analysts forecast that Paysign will post 0.22 EPS for the current fiscal year.

Insider Activity at Paysign

In other news, CFO Jeffery Bradford Baker sold 27,691 shares of the firm’s stock in a transaction on Monday, March 4th. The stock was sold at an average price of $2.87, for a total value of $79,473.17. Following the completion of the sale, the chief financial officer now owns 157,097 shares of the company’s stock, valued at $450,868.39. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, insider Topline Capital Management, Ll acquired 25,736 shares of the company’s stock in a transaction on Friday, February 16th. The shares were purchased at an average price of $3.03 per share, for a total transaction of $77,980.08. Following the purchase, the insider now owns 5,710,392 shares in the company, valued at $17,302,487.76. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Jeffery Bradford Baker sold 27,691 shares of the business’s stock in a transaction on Monday, March 4th. The shares were sold at an average price of $2.87, for a total transaction of $79,473.17. Following the transaction, the chief financial officer now owns 157,097 shares in the company, valued at $450,868.39. The disclosure for this sale can be found here. In the last 90 days, insiders bought 476,086 shares of company stock worth $1,416,208. 23.30% of the stock is owned by corporate insiders.

Institutional Trading of Paysign

Institutional investors have recently bought and sold shares of the company. Norden Group LLC raised its stake in shares of Paysign by 38.7% during the 1st quarter. Norden Group LLC now owns 14,883 shares of the company’s stock worth $54,000 after purchasing an additional 4,151 shares in the last quarter. Bridge City Capital LLC bought a new stake in Paysign in the third quarter worth approximately $61,000. Portside Wealth Group LLC increased its stake in shares of Paysign by 33.7% during the 3rd quarter. Portside Wealth Group LLC now owns 33,740 shares of the company’s stock worth $68,000 after purchasing an additional 8,508 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. lifted its stake in shares of Paysign by 18.2% in the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 38,205 shares of the company’s stock valued at $74,000 after purchasing an additional 5,874 shares during the last quarter. Finally, Spouting Rock Asset Management LLC boosted its holdings in Paysign by 39.0% in the third quarter. Spouting Rock Asset Management LLC now owns 38,167 shares of the company’s stock worth $74,000 after purchasing an additional 10,700 shares in the last quarter. Institutional investors and hedge funds own 25.89% of the company’s stock.

About Paysign

Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.